NCT00454753|Unknown
Expanded Access for Dasatinib
1 other identifier
CA180-109
Study Type
expanded_access
Target
N/A
Locations
0 countries
Sites
N/A
Timeline
RegisteredApr 2007
Brief Summary
This is an expanded access designed to provide access to dasatinib for eligible participants.
Trial Health
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 30, 2007
Completed3 days until next milestone
First Posted
Study publicly available on registry
April 2, 2007
CompletedLast Updated
April 29, 2022
Status Verified
April 1, 2022
First QC Date
March 30, 2007
Last Update Submit
April 25, 2022
Interventions
DasatinibDRUG
Sponsors & Collaborators
Related Links
MeSH Terms
Interventions
Dasatinib
Intervention Hierarchy (Ancestors)
ThiazolesSulfur CompoundsOrganic ChemicalsAzolesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsPyrimidines
Study Officials
- STUDY DIRECTOR
Bristol-Myers Squibb
Bristol-Myers Squibb, Korea
Study Design
- Study Type
- expanded access
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 30, 2007
First Posted
April 2, 2007
Last Updated
April 29, 2022
Record last verified: 2022-04